Develops non-invasive neuroprotective therapies for neurodegenerative diseases, with a primary focus on Alzheimer’s disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Cognito Therapeutics develops non-invasive neuroprotective therapies for neurodegenerative diseases, with a primary focus on Alzheimer’s disease. Their Spectris platform uses audiovisual stimulation to evoke specific brain wave activity, aiming to preserve brain structure, cognition, and function in patients living with Alzheimer’s.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Cognito Therapeutics Management Team
Investors
Alzheimer’s Drug Discovery Foundation (ADDF)
Apollo Health Ventures
Benvolio Group
FoundersX Ventures
IAG Capital Partners
Morningside Ventures
New Vintage
Starbloom Capital
Wilson Sonsini Investments (WS Investments)
Cognito Therapeutics Valuations & Financials
View real-time NPM data on Cognito Therapeutics stock including daily Cognito Therapeutics stock price estimates, valuation history, and historical share price information. Access Cognito Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Cognito Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Cognito Therapeutics? Get in touch to learn more.
Similar Companies
like Cognito Therapeutics
CareTaker Medical
Healthcare & Life Sciences
Replaces invasive monitoring with wireless sensors delivering real-time vital signs for improved clinical decision-making.
Aptitude Medical Systems
Healthcare & Life Sciences
Provides portable molecular testing which expands access to in‑home and point‑of‑care health screening.
Riva Health
Healthcare & Life Sciences
Builds mobile platforms that monitor heart health and promote proactive, individualized care.
Aurie
Healthcare & Life Sciences
Delivers a catheter system that enables reuse with automated cleaning and hygiene safeguards.
EnsoData
Healthcare & Life Sciences
Interprets sleep and respiratory data to deliver clinical insights and streamline care workflows.
Pair Team
Healthcare & Life Sciences
Link vulnerable people that receive medical, behavioral, and social services through a unified, care-coordinated hub.
Ceresti Health
Healthcare & Life Sciences
Activates caregivers with personalized support resources to improve dementia care and lower avoidable acute incidents.
Modern Clinics
Healthcare & Life Sciences
Delivering integrated primary and aesthetic care through tech-enabled clinics that blend diagnostics, prevention, and beauty in one seamless experience.
ClearCam
Healthcare & Life Sciences
Provides real‑time in‑body cleaning of laparoscopic lenses to maintain clear vision during surgery.
FAQ
We have answers
Cognito Therapeutics stock does not trade on public stock exchanges. Cognito Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Cognito Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Cognito Therapeutics Stock does not trade on public stock exchanges. In order to sell Cognito Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Cognito Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Cognito Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Cognito Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Cognito Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Cognito Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Cognito Therapeutics is a private company and has not had an IPO. There is currently no Cognito Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Cognito Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
